Lipoprotein Nanoplatform for Targeted Delivery of Diagnostic and Therapeutic Agents
Low-density lipoprotein (LDL) provides a highly versatile natural nanoplatform for delivery of visible or near-infrared fluorescent optical and magnetic resonance imaging (MRI) contrast agents and photodynamic therapy and chemotherapeutic agents to normal and neoplastic cells that overexpress low-de...
Main Authors: | Jerry D. Glickson, Sissel Lund-Katz, Rong Zhou, Hoon Choi, I-Wei Chen, Hui Li, Ian Corbin, Anatoliy V. Popov, Weiguo Cao, Liping Song, Chenze Qi, Diane Marotta, David S. Nelson, Juan Chen, Britton Chance, Gang Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2008-03-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2008.0012 |
Similar Items
-
Low-Density Lipoprotein Nanoparticles as Magnetic Resonance Imaging Contrast Agents
by: Ian R. Corbin, et al.
Published: (2006-06-01) -
Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics
by: Chao Liu, et al.
Published: (2017-11-01) -
Surface plasmon resonance analysis of the mechanism of binding of apoA-I to high density lipoprotein particles
by: Sissel Lund-Katz, et al.
Published: (2010-03-01) -
Exosomes as Smart Nanoplatforms for Diagnosis and Therapy of Cancer
by: Yuying Zhao, et al.
Published: (2021-08-01) -
Bioinspired Membrane-Coated Nanoplatform for Targeted Tumor Immunotherapy
by: Dan Mu, et al.
Published: (2022-01-01)